- A pioneering blood test has been found to predict a woman's risk of developing dementia up to 25 years before symptoms manifest.
- US experts discovered that elevated levels of p-tau217, a protein associated with Alzheimer's disease, accurately forecast future cognitive decline.
- The study, conducted by the University of California San Diego, analysed data from 2,766 women aged 65 to 79 over a 25-year period.
- Researchers observed that women with higher initial p-tau217 levels were significantly more likely to develop dementia later in life.
- British researchers welcomed the findings, emphasising the rapid advancements in developing early Alzheimer's detection blood tests for potential future use.
IN FULL
